Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Stomach Neoplasms 1Small Cell Lung Carcinoma 1Pyloric Stenosis, Hypertrophic 1Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Esophageal Neoplasms 1Carcinoma, Basal Cell 1Basal Cell Nevus Syndrome 1

Interventions

tazarotene 2gusacitinib 2Photochemotherapy 2IPI-926 2HhAntag691 2Drug Evaluation 2Aminolevulinic Acid 21-phenyl-3,3-dimethyltriazene 2sonidegib 1merphos 1Vincristine 1Solutions 1Sirolimus 1Red Light 1Microarray Analysis 1Methotrexate 1Mental Status and Dementia Tests 1Mass Spectrometry 1Gene Expression Profiling 1Fluorouracil 1Etoposide 1Cyclophosphamide 1Comparative Genomic Hybridization 1Carnitine 1Carboplatin 1Blue Light 1Biopsy 1BMS-833923 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Basal Cell Nevus Syndrome × BMS-833923 × Clear all
NCT02100371 2017-07-11

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

University Health Network, Toronto

Phase NA Completed
2 enrolled
Dermatologic

Basal Cell Nevus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡